SCHEMBL22947384

SCHEMBL22947384

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3-c3ccccc3S4(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.40
ADORA1 P30542 3/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA2B P29275 2/20 0.40
TSHR P16473 2/20 0.40
ALOX15 P16050 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
DPP4 P27487 6/20 0.37
POLB P06746 1/20 0.34
MEN1 O00255 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
KMT2A Q03164 3/20 0.33
ADK P55263 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 2/20 0.33
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22949634 0.97 ADORA3 (0.38) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947637 0.97 ADORA3 (0.38) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22948448 0.96 TSHR (0.37) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947426 0.94 ADORA2A (0.38) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947375 0.93 SMN1; SMN2 (0.40) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22948675 0.93 MEN1 (0.36) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22948595 0.93 ADORA2A (0.35) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947349 0.93 ADORA2A (0.35) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947525 0.92 ADORA3 (0.39) ADORA2AADORA1ADORA3ADORA2BTSHR
SCHEMBL22947671 0.91 ADORA3 (0.38) ADORA2AADORA1ADORA3ADORA2BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 ADORA2A 4133/4885ADORA1 4602/4885ADORA3 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.